Evidence map›Paper›PMID 36305336›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021.

Torsten Houwaart, Samir Belhaj, Emran Tawalbeh, Dirk Nagels, Yara Fröhlich, Patrick Finzer, Pilar Ciruela, Aurora Sabrià, Mercè Herrero, Cristina Andrés and 38 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Torsten HouwaartInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Samir BelhajDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Emran TawalbehDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Dirk NagelsDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Yara FröhlichInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Patrick FinzerInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Pilar CiruelaSub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Barcelona, Spain.
Aurora SabriàSub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Barcelona, Spain.
Mercè HerreroSub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Barcelona, Spain.
Cristina AndrésMicrobiology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Andrés AntónMicrobiology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Assia BenmoumeneInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Dounia AsskaliInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Hussein HaidarInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Janina von DahlenInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Jessica NicolaiInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Mygg StillerMedizinische Laboratorien Düsseldorf, Düsseldorf, Germany.
Jacqueline BlumMedizinische Laboratorien Düsseldorf, Düsseldorf, Germany.
Christian LangeMedizinische Laboratorien Düsseldorf, Düsseldorf, Germany.
Carla AdelmannSolingen Health Authority (Gesundheitsamt Solingen), Solingen, Germany.
Britta SchroerSolingen Health Authority (Gesundheitsamt Solingen), Solingen, Germany.
Ute OsmersMVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
Christiane GriceMVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
Phillipp P KirfelMVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
Hassan JomaaMVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
Daniel StrelowInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Lisanna HülseInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Moritz PigullaDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Pascal KreuzerDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Alona TyshaievaInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Jonas WeberInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Tobias WienemannInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Malte Kohns VasconcelosInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Katrin HoffmannZotz | Klimas, Düsseldorf, Germany.
Nadine LübkeInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Sandra HaukaInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Marcel AndreeInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Claus Jürgen ScholzLabor Dr. Wisplinghoff, Cologne, Germany.
Nathalie JazmatiLabor Dr. Wisplinghoff, Cologne, Germany.
Klaus GöbelsDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Rainer ZotzDepartment of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany.
Klaus PfefferInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Jörg TimmInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Lutz EhlkesDüsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
Andreas WalkerInstitute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Alexander T DiltheyInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
German COVID-19 OMICS Initiative (DeCOI)Members of German COVID-19 OMICS Initiative (DeCOI) are listed under Collaborators.
German COVID-19 OMICs Initiative (DeCOI)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundTracking person-to-person SARS-CoV-2 transmission in the population is important to understand the epidemiology of community transmission and may contribute to the containment of SARS-CoV-2. Neither contact tracing nor genomic surveillance alone, however, are typically sufficient to achieve this objective.AimWe demonstrate the successful application of the integrated genomic surveillance (IGS) system of the German city of Düsseldorf for tracing SARS-CoV-2 transmission chains in the population as well as detecting and investigating travel-associated SARS-CoV-2 infection clusters.MethodsGenomic surveillance, phylogenetic analysis, and structured case interviews were integrated to elucidate two genetically defined clusters of SARS-CoV-2 isolates detected by IGS in Düsseldorf in July 2021.ResultsCluster 1 (n = 67 Düsseldorf cases) and Cluster 2 (n = 36) were detected in a surveillance dataset of 518 high-quality SARS-CoV-2 genomes from Düsseldorf (53% of total cases, sampled mid-June to July 2021). Cluster 1 could be traced back to a complex pattern of transmission in nightlife venues following a putative importation by a SARS-CoV-2-infected return traveller (IP) in late June; 28 SARS-CoV-2 cases could be epidemiologically directly linked to IP. Supported by viral genome data from Spain, Cluster 2 was shown to represent multiple independent introduction events of a viral strain circulating in Catalonia and other European countries, followed by diffuse community transmission in Düsseldorf.ConclusionIGS enabled high-resolution tracing of SARS-CoV-2 transmission in an internationally connected city during community transmission and provided infection chain-level evidence of the downstream propagation of travel-imported SARS-CoV-2 cases.

Indexed as

Communicable Diseases, ImportedCOVID-19Contact TracingGenomicsGermanyHumansPhylogenySARS-CoV-2Travelcontact tracingdeep backward contact tracingGenomic surveillanceNanopore real-time sequencingNext generation sequencingSARS-CoV-2travel-associated SARS-CoV-2 infections

Identifiers

PMID36305336
PMCPMC9615415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.